These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36803898)
1. Construction and efficacy of a new live chimeric C-strain vaccine with DIVA characteristics against classical swine fever. Yi W; Wang H; Qin H; Wang Q; Guo R; Wen G; Pan Z Vaccine; 2023 Mar; 41(12):2003-2012. PubMed ID: 36803898 [TBL] [Abstract][Full Text] [Related]
2. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response. van Gennip HG; van Rijn PA; Widjojoatmodjo MN; de Smit AJ; Moormann RJ Vaccine; 2000 Oct; 19(4-5):447-59. PubMed ID: 11027808 [TBL] [Abstract][Full Text] [Related]
3. The recombinant E Yi W; Zhu H; Wu Y; Li Q; Lou W; Zhao H; Pan Z Virol J; 2022 Jul; 19(1):121. PubMed ID: 35869505 [TBL] [Abstract][Full Text] [Related]
4. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Reimann I; Depner K; Trapp S; Beer M Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124 [TBL] [Abstract][Full Text] [Related]
5. Genetically distinct pestiviruses pave the way to improved classical swine fever marker vaccine candidates based on the chimeric pestivirus concept. Postel A; Becher P Emerg Microbes Infect; 2020 Dec; 9(1):2180-2189. PubMed ID: 32962557 [TBL] [Abstract][Full Text] [Related]
6. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs. de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670 [TBL] [Abstract][Full Text] [Related]
7. The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge. Li Y; Yuan M; Han Y; Xie L; Ma Y; Li S; Sun Y; Luo Y; Li W; Qiu HJ J Virol; 2022 Jan; 96(2):e0176821. PubMed ID: 34730400 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics. Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the efficacy of an attenuated live marker classical swine fever vaccine (Flc-LOM-BE Lim SI; Choe S; Kim KS; Jeoung HY; Cha RM; Park GS; Shin J; Park GN; Cho IS; Song JY; Hyun BH; Park BK; An DJ Vaccine; 2019 Jun; 37(27):3598-3604. PubMed ID: 31151802 [TBL] [Abstract][Full Text] [Related]
10. Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV. van Gennip HG; Bouma A; van Rijn PA; Widjojoatmodjo MN; Moormann RJ Vaccine; 2002 Feb; 20(11-12):1544-56. PubMed ID: 11858861 [TBL] [Abstract][Full Text] [Related]
11. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections. Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514 [TBL] [Abstract][Full Text] [Related]
12. Generation and Efficacy of Two Chimeric Viruses Derived from GPE Huynh LT; Isoda N; Hew LY; Ogino S; Mimura Y; Kobayashi M; Kim T; Nishi T; Fukai K; Hiono T; Sakoda Y Viruses; 2023 Jul; 15(7):. PubMed ID: 37515273 [TBL] [Abstract][Full Text] [Related]
13. Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines. Wehrle F; Renzullo S; Faust A; Beer M; Kaden V; Hofmann MA J Gen Virol; 2007 Aug; 88(Pt 8):2247-2258. PubMed ID: 17622629 [TBL] [Abstract][Full Text] [Related]
14. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif. von Rosen T; Rangelova D; Nielsen J; Rasmussen TB; Uttenthal Å Vet Microbiol; 2014 Jun; 170(3-4):224-31. PubMed ID: 24629779 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain. Xia SL; Xiang GT; Lei JL; Du M; Wang Y; Zhou M; Liu Y; Ji S; Wang YL; Luo Y; Sun Y; Qiu HJ Vet Microbiol; 2016 Nov; 196():50-54. PubMed ID: 27939155 [TBL] [Abstract][Full Text] [Related]
16. P108 and T109 on E2 Glycoprotein Domain I Are Critical for the Adaptation of Classical Swine Fever Virus to Rabbits but Not for Virulence in Pigs. Xie L; Han Y; Ma Y; Yuan M; Li W; Li LF; Li M; Sun Y; Luo Y; Li S; Hu S; Li Y; Qiu HJ J Virol; 2020 Aug; 94(17):. PubMed ID: 32581110 [TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of the Erns protein of classical swine fever virus in yeast and its application in an indirect enzyme-linked immunosorbent assay for antibody differentiation of infected from vaccinated animals. Luo Y; Li L; Austermann-Busch S; Dong M; Xu J; Shao L; Lei J; Li N; He WR; Zhao B; Li S; Li Y; Liu L; Becher P; Sun Y; Qiu HJ J Virol Methods; 2015 Sep; 222():22-7. PubMed ID: 26005003 [TBL] [Abstract][Full Text] [Related]
18. Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs. Tignon M; Kulcsár G; Haegeman A; Barna T; Fábián K; Lévai R; Van der Stede Y; Farsang A; Vrancken R; Belák K; Koenen F Vet Microbiol; 2010 Apr; 142(1-2):59-68. PubMed ID: 19857935 [TBL] [Abstract][Full Text] [Related]
19. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies. Aebischer A; Müller M; Hofmann MA Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189 [TBL] [Abstract][Full Text] [Related]
20. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV). Koenig P; Lange E; Reimann I; Beer M Vaccine; 2007 Apr; 25(17):3391-9. PubMed ID: 17257713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]